Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Piga

Showing results (131-140 of 191) with videos related to

Pageof 20
Sort By:
Rheumatology (Oxford, England)|November 15, 2011
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patientsMarcello Govoni, Stefano Bombardieri, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|January 21, 2026
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohortFulvia Ceccarelli, Matteo Piga, Francesca Romana Spinelli, et al.
Clinical and Experimental Rheumatology|July 27, 2022
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosusImmacolata Prevete, Annamaria Iuliano, Alberto Cauli, et al.
Rheumatology (Oxford, England)|June 28, 2013
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09Alberto Cauli, Jacqueline Shaw, Joanna Giles, et al.
Autoimmunity Reviews|February 17, 2025
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task forceMatteo Piga, Ioannis Parodis, Zahi Touma, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Comparative study between two European inception cohorts of patients with early systemic lupus erythematosusImmacolata Prevete, Gerard Espinosa, Francesca Bellisai, et al.
Rheumatology (Oxford, England)|February 18, 2026
The use of non-TNF targeted biologics in Behçet's Disease: Real-life data from the International AIDA Network Behçet's Disease RegistryGizem Sevik, Giuseppe Lopalco, Florenzo Iannone, et al.
The Journal of Rheumatology|July 1, 2024
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter StudyChiara Tani, Chiara Cardelli, Margherita Zen, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Annals of the Rheumatic Diseases|October 17, 2024
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trialRosaria Talarico, Nazzareno Italiano, Giacomo Emmi, et al.
Pageof 20

Showing results (131-140 of 191) with videos related to

Sort By:
Pageof 20
Rheumatology (Oxford, England)|November 15, 2011
Factors and comorbidities associated with first neuropsychiatric event in systemic lupus erythematosus: does a risk profile exist? A large multicentre retrospective cross-sectional study on 959 Italian patientsMarcello Govoni, Stefano Bombardieri, Alessandra Bortoluzzi, et al.
Clinical and Experimental Rheumatology|January 21, 2026
Application of lupus comprehensive disease control in newly diagnosed systemic lupus erythematosus patients: results from the Italian multicentre Early Lupus Project inception cohortFulvia Ceccarelli, Matteo Piga, Francesca Romana Spinelli, et al.
Clinical and Experimental Rheumatology|July 27, 2022
Similarities and differences between younger and older disease onset patients with newly diagnosed systemic lupus erythematosusImmacolata Prevete, Annamaria Iuliano, Alberto Cauli, et al.
Rheumatology (Oxford, England)|June 28, 2013
The arthritis-associated HLA-B*27:05 allele forms more cell surface B27 dimer and free heavy chain ligands for KIR3DL2 than HLA-B*27:09Alberto Cauli, Jacqueline Shaw, Joanna Giles, et al.
Autoimmunity Reviews|February 17, 2025
Framework for implementing treat-to-target in systemic lupus erythematosus routine clinical care: consensus statements from an international task forceMatteo Piga, Ioannis Parodis, Zahi Touma, et al.
Clinical and Experimental Rheumatology|January 24, 2020
Comparative study between two European inception cohorts of patients with early systemic lupus erythematosusImmacolata Prevete, Gerard Espinosa, Francesca Bellisai, et al.
Rheumatology (Oxford, England)|February 18, 2026
The use of non-TNF targeted biologics in Behçet's Disease: Real-life data from the International AIDA Network Behçet's Disease RegistryGizem Sevik, Giuseppe Lopalco, Florenzo Iannone, et al.
The Journal of Rheumatology|July 1, 2024
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter StudyChiara Tani, Chiara Cardelli, Margherita Zen, et al.
Rheumatology (Oxford, England)|February 25, 2024
Therapeutic strategies and outcomes in neuropsychiatric systemic lupus erythematosus: an international multicentre retrospective studyAlessandra Bortoluzzi, Antonis Fanouriakis, Ettore Silvagni, et al.
Annals of the Rheumatic Diseases|October 17, 2024
Efficacy and safety of infliximab or adalimumab in severe mucocutaneous Behçet's syndrome refractory to traditional immunosuppressants: a 6-month, multicentre, randomised controlled, prospective, parallel group, single-blind trialRosaria Talarico, Nazzareno Italiano, Giacomo Emmi, et al.
Pageof 20